• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM; PERIPHERAL ATHERECTOMY DEVICE Back to Search Results
Model Number DBP-200SOLID145
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Embolism/Embolus (4438)
Event Date 09/16/2020
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive since the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history record for this oad lot number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements prior to distribution.Csi id: (b)(4).
 
Event Description
A diamondback peripheral orbital atherectomy device (oad) was used to treat a lesion in the common femoral artery (cfa) and a chronic total occlusion in the superficial femoral artery (sfa).Following balloon angioplasty and stent placement in the sfa, atherectomy was performed in the cfa on low and medium speeds.A treatment pass was performed on high speed in the cfa and the crown engaged the proximal sfa, resulting in an embolus of calcified material traveling down stream.Distal flow was occluded, and a filter device was used to remove a portion of the embolus.There was a visible embolism in the tibial vessels, and a catheter was placed for tissue plasminogen activator (tpa) therapy.The tpa therapy was performed overnight, following which the patient was in stable condition with continued leg ischemia.On (b)(6) 2020, a bilateral fasciotomy and thrombectomy was performed.The patient was in stable condition following the procedure and was discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIAMONDBACK 360 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
Type of Device
PERIPHERAL ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC.
1225 old highway 8 nw
st. paul, mn MN 55112
Manufacturer (Section G)
CARDIOVASCULAR SYSTEMS, INC.
1225 old highway 8 nw
st. paul, mn MN 55112
Manufacturer Contact
laramie otto
1225 old highway 8 nw
st. paul, mn, MN 55112
6512591600
MDR Report Key10622131
MDR Text Key209653428
Report Number3004742232-2020-00298
Device Sequence Number1
Product Code MCW
UDI-Device Identifier10850000491202
UDI-Public(01)10850000491202(17)220430(17)321392
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190634
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 10/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2022
Device Model NumberDBP-200SOLID145
Device Catalogue Number7-10057-04
Device Lot Number321392
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/16/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/02/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age77 YR
-
-